10-K.Info (Beta Test)
Courtesy of Short Sands, LLC
10-K.Info (Beta Test)
Courtesy of Short Sands, LLC

AMGEN INC

Ticker: AMGN   Fiscal Year: 2021

Consolidated Statements of Income

Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022)

(In Millions)
 12 Months Ended12 Months Ended12 Months Ended
 Dec 31, 2021Dec 31, 2020Dec 31, 2019
Revenues:
Total revenues
$
25,979
25,42423,362
Operating expenses:
Cost of sales6,4546,1594,356
Research and development4,8194,2074,116
Acquired in-process research and development1,50500
Selling, general and administrative5,3685,7305,150
Other19418966
Total operating expenses18,34016,28513,688
 
Operating income7,6399,1399,674
 
Interest expense, net(1,197)(1,262)(1,289)
Other income, net259256753
Income before income taxes6,7018,1339,138
 
Provision for income taxes8088691,296
Net income5,8937,2647,842
 
Earnings per share:
Basic (in usd per share)10.3412.4012.96
Diluted (in usd per share)10.2812.3112.88
Shares used in the calculation of earnings per share:
Basic (in shares)570586605
Diluted (in shares)573590609
Product and Service
Product sales
Total revenues24,29724,24022,204
Other revenues
Total revenues1,6821,1841,158
External Links 
AMGEN INC (AMGN) Fiscal Year 2021
Statements of 10-K in Excel https://www.sec.gov/.../Financial.xlxs
Complete 10-K in HTML https://www.sec.gov/.../10-K.html
Complete 10-K in XBRL https://www.sec.gov/.../10-K-xbrl.zip